Zantac / Ranitidine (NDMA Cancer) Lawsuit in Oklahoma

Preparing your case review…
Written By
People's Justice Legal Research Team

Statute of Limitations

Oklahoma imposes a 2-year statute of limitations for personal injury claims (12 O.S. § 95). The discovery rule applies to latent pharmaceutical injury cases. Oklahoma courts apply Daubert under 12 O.S. § 2702. Oklahoma Zantac claimants with 2024 or later diagnoses should act promptly; earlier diagnoses require discovery rule analysis with qualified counsel.

2 years from date of cancer diagnosis discovery (Daubert expert standard)

Oklahoma Data

Exposure in Oklahoma

Source: U.S. Census Bureau 2024

Source: Delaware litigation tracking 2025

Medical Resources

Clinics & Specialists in Oklahoma

Stephenson Cancer Center (OU Health)

Cancer Treatment Centers of America (CTCA) Tulsa

Back to Zantac / Ranitidine (NDMA Cancer) Lawsuit Overview